HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.

Abstract
The T-cell leukemia 1 (TCL1) oncoprotein is overexpressed by chromosomal rearrangement in the majority of cases of T-cell prolymphocytic leukemia (T-PLL). In vitro, TCL1 can modulate the activity of the serine-threonine kinase AKT, a downstream effector of T-cell receptor (TCR) signaling. In a series of 86 T-PLL tumors, we show that expression of TCR, and levels of TCL1 and activated AKT are adverse prognostic markers. High-level TCL1 in TCR-expressing T-PLL is associated with higher presenting white blood cell counts, faster tumor cell doubling, and enhanced in vitro growth response to TCR engagement. In primary tumors and TCL1-transfected T-cell lines, TCR engagement leads to rapid recruitment of TCL1 and AKT to transient membrane activation complexes that include TCR-associated tyrosine kinases, including LCK. Pharmacologic inhibition of AKT activation alters the localization, stability, and levels of these transient TCL1-AKT complexes and reduces tumor cell growth. Experimental introduction and knockdown of TCL1 influence the kinetics and strength of TCR-mediated AKT activation. We propose that in T-PLL, TCL1 represents a highly regulated, targetable modulator of TCR-mediated AKT growth signaling.
AuthorsMarco Herling, Kaushali A Patel, Michael A Teitell, Marina Konopleva, Farhad Ravandi, Ryuji Kobayashi, Dan Jones
JournalBlood (Blood) Vol. 111 Issue 1 Pg. 328-37 (Jan 01 2008) ISSN: 0006-4971 [Print] United States
PMID17890451 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Proto-Oncogene Proteins
  • Receptors, Antigen, T-Cell
  • TCL1A protein, human
  • Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins c-akt
Topics
  • Cell Division (physiology)
  • Gene Expression Regulation, Leukemic
  • Humans
  • Immunophenotyping
  • Leukemia, Prolymphocytic (genetics, metabolism, pathology)
  • Leukemia, T-Cell (genetics, metabolism, pathology)
  • Phosphorylation
  • Protein-Tyrosine Kinases (metabolism)
  • Proto-Oncogene Proteins (genetics, metabolism)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Receptors, Antigen, T-Cell (metabolism)
  • Signal Transduction (immunology)
  • T-Lymphocytes (pathology, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: